| Product Code: ETC8275893 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Complete Androgen Insensitivity Syndrome Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Complete Androgen Insensitivity Syndrome Market - Industry Life Cycle |
3.4 Mexico Complete Androgen Insensitivity Syndrome Market - Porter's Five Forces |
3.5 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.6 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Complete Androgen Insensitivity Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about androgen insensitivity syndrome (AIS) and its diagnosis in Mexico |
4.2.2 Advances in medical research leading to better understanding and treatment options for AIS |
4.2.3 Government initiatives to improve healthcare access and support for individuals with rare genetic conditions like AIS |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals with expertise in managing AIS |
4.3.2 High treatment costs associated with hormone replacement therapy and potential surgeries for individuals with AIS in Mexico |
5 Mexico Complete Androgen Insensitivity Syndrome Market Trends |
6 Mexico Complete Androgen Insensitivity Syndrome Market, By Types |
6.1 Mexico Complete Androgen Insensitivity Syndrome Market, By Symptoms |
6.1.1 Overview and Analysis |
6.1.2 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Symptoms, 2021- 2031F |
6.1.3 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Abnormally Tall Stature, 2021- 2031F |
6.1.4 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Little or No Pubic Hair, 2021- 2031F |
6.1.5 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Shallow Vagina, 2021- 2031F |
6.1.6 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Undescended Testicles, 2021- 2031F |
6.1.7 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Amenorrhea, 2021- 2031F |
6.1.8 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mexico Complete Androgen Insensitivity Syndrome Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.2.3 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.2.4 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Pelvic Ultrasound, 2021- 2031F |
6.2.5 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mexico Complete Androgen Insensitivity Syndrome Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3.3 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Estrogen Replacement Therapy, 2021- 2031F |
6.3.4 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Genetic Counselling, 2021- 2031F |
6.3.5 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Hormone Medications, 2021- 2031F |
6.3.6 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mexico Complete Androgen Insensitivity Syndrome Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Mexico Complete Androgen Insensitivity Syndrome Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Mexico Complete Androgen Insensitivity Syndrome Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Mexico Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Complete Androgen Insensitivity Syndrome Market Import-Export Trade Statistics |
7.1 Mexico Complete Androgen Insensitivity Syndrome Market Export to Major Countries |
7.2 Mexico Complete Androgen Insensitivity Syndrome Market Imports from Major Countries |
8 Mexico Complete Androgen Insensitivity Syndrome Market Key Performance Indicators |
8.1 Number of healthcare facilities offering specialized services for AIS in Mexico |
8.2 Percentage increase in early diagnosis rates of AIS cases in Mexico |
8.3 Patient satisfaction scores related to the quality of care and support received for AIS in Mexico |
9 Mexico Complete Androgen Insensitivity Syndrome Market - Opportunity Assessment |
9.1 Mexico Complete Androgen Insensitivity Syndrome Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.2 Mexico Complete Androgen Insensitivity Syndrome Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Mexico Complete Androgen Insensitivity Syndrome Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Mexico Complete Androgen Insensitivity Syndrome Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Mexico Complete Androgen Insensitivity Syndrome Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Mexico Complete Androgen Insensitivity Syndrome Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Complete Androgen Insensitivity Syndrome Market - Competitive Landscape |
10.1 Mexico Complete Androgen Insensitivity Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Mexico Complete Androgen Insensitivity Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here